3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
277
Precursor Cell Lymphoblastic Leukemia-Lymphoma
55
Recurrence
43
Neoplasms, Plasma Cell
32
Leukemia
29
Lymphoma
25
Neoplasms
23
Vomiting
21
Burkitt Lymphoma
20
Lymphoma, Non-Hodgkin
19
Nausea
17
Immunoglobulin Light-chain Amyloidosis
17
Lymphoma, Mantle-Cell
16
Carcinoma, Non-Small-Cell Lung
15
Prostatic Neoplasms
14
Waldenstrom Macroglobulinemia
13
Lymphoma, Follicular
13
Breast Neoplasms
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma, Large B-Cell, Diffuse
11
Leukemia, Myeloid, Acute
10
Lymphoma, B-Cell, Marginal Zone
9
Amyloidosis
9
Leukemia, Lymphocytic, Chronic, B-Cell
8
Hodgkin Disease
8
Neoplasm Metastasis
7
Hematologic Neoplasms
7
Smoldering Multiple Myeloma
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Interventions
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Genital Diseases, Female
×
Dexamethasone
×
Clear all
No trials found.